Seeking Alpha

Jessica King Holden

View as an RSS Feed
View Jessica King Holden's Articles BY TICKER:
  • Vonage Builds Valuable Intellectual Property
    on Jul. 10, 2012 CHTR, CMCSA, DISH 4 Comments
  • Which Mid-June Summer Biotech Romance Will Last?
    on Jun. 18, 2012 ARNA, JNJ, ROSG 11 Comments
  • A Long Shot In The Lupus Market Gains Attention
    on Jun. 15, 2012 BMY, MRK, GSK 5 Comments
  • Catalyst And Questions For 2 Biotech Movers
    on Jun. 6, 2012 ABT, AGN, AUXL 5 Comments
  • Playing OncoGenex's ASCO Data
    on Jun. 4, 2012 ISIS, JNJ, PSA 1 Comment
  • 3 Biotech Stocks With Key FDA Summer Dates
    on May. 30, 2012 ARIA, ARNA, MRK 7 Comments
  • Vertex's Data Bungle Offers Entry Point
    on May. 29, 2012 VRTX 1 Comment
  • ASCO Stocks To Consider This Week
    on May. 29, 2012 ARNA, BAYRY, JNJ 2 Comments
  • 3 Biotech Stocks On The Move
    on May. 22, 2012 GENE, ISIS, ROSG 2 Comments
  • Isis: A Pick To Win The Biotech Derby
    on May. 10, 2012 ARNA, BIIB, GSK 16 Comments
  • 3 Biotechs To Watch This Week
    on May. 8, 2012 ARNA, SRPT, OREX 4 Comments
  • 7 Summer Sports Stocks To Consider
    on May. 3, 2012 BUD, HNZ, MDLZ 1 Comment
  • Stocks For A Summer Road Trip
    on May. 2, 2012 DIS, HOG, MCD 2 Comments
  • Friday's U.S. Top Gainers Have A Biotech Flavor
    on Apr. 27, 2012 ARNA, OREX, REGN 10 Comments
  • Cobra Gets It Right In The First Quarter
    on Apr. 27, 2012 COBR Comment!
  • Rare Disease Stocks With Takeover Potential
    on Apr. 24, 2012 ALXN, AZN, BMRN Comment!
  • 2 Biotechs To Watch Near-Term
    on Apr. 19, 2012 BIO, GSK, ILMN 2 Comments
  • 5 Year Projection: Here Comes The Sun?
    on Apr. 18, 2012 CLR, LB, FSLR 3 Comments
  • EDAP: Now A Compelling Prostate Cancer Play
    on Apr. 17, 2012 EDAP 4 Comments
  • Wal-Mart Gets Into Diabetic Neuropathy Testing
    on Apr. 2, 2012 CVS, NURO, WAG 6 Comments
  • Lightening The Backpack Of Education: E-Readers And E-Textbooks
    on Mar. 30, 2012 AAPL, PSO, AMZN 3 Comments
  • Patent Cliff Offers Entry Dips
    on Mar. 19, 2012 AZN, GSK, TEVA 2 Comments
  • Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
    on Mar. 8, 2012 AAPL, LLY, TKPHF 4 Comments
  • Cashing In On Diabetes: Novel Approaches
    on Mar. 7, 2012 BAX, RHHBY, ECTE 3 Comments
  • Cashing In On Diabetes: The Race To The Artificial Pancreas
    on Mar. 7, 2012 ABT, DXCM, JNJ 5 Comments
  • 4 Rare Disease Stocks
    on Mar. 1, 2012 SHPG, GEVA, ISIS 7 Comments
  • Biotech Stocks To Consider Going Into Earnings
    on Feb. 29, 2012 ASTX, EBS, ESALY 3 Comments
  • Isis: If Trend Holds True, Watch For A Leap After Earnings
    on Feb. 28, 2012 ISIS 3 Comments
  • Jazz Pharmaceuticals Can Hit An Interesting Note In 2012
    on Feb. 26, 2012 AZN, COV, ELN 2 Comments
  • Cobra Navigating Down For Now, But Not Out
    on Feb. 24, 2012 GRMN, TRMB, VOXX 1 Comment
  • Cobra Poised To Move On Earnings Release
    on Feb. 23, 2012 GOOG, VOXX, GRMN 2 Comments
  • Why Herbalife Will Not Be Killed By Prescription Weight Loss Drugs
    on Feb. 23, 2012 VVUS, ARNA, OREX 8 Comments